We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News

Medical news

Ask MedXY AI
Hypertension managementType 2 diabetesHeart failure follow-upPneumonia antibiotics
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationcritical carebiomarkersclinical trialsartificial intelligenceHypertensionCardiologyoncologytype 1 diabetespublic healthMortalitydiabetesAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Unexpected Early Postoperative Lipid Deterioration in Cushing’s Syndrome: Implications for Cardiovascular Risk and Management
Cardiologycardiovascular riskCushing's Syndrome

Unexpected Early Postoperative Lipid Deterioration in Cushing’s Syndrome: Implications for Cardiovascular Risk and Management

By MedXY|Sep 22, 2026

This study reveals that lipid profiles paradoxically worsen during the early remission phase after curative surgery for Cushing’s syndrome, highlighting a critical window for cardiovascular risk and targeted intervention.

Gene Editing Therapy in Cardiovascular Disease: Key Takeaways from the 2026 ACC Scientific Statement
CardiologyACCcardiovascular

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles

Gene Editing Therapy in Cardiovascular Disease: Key Takeaways from the 2026 ACC Scientific Statement

By MedXY|Sep 22, 2026

A clinician-focused summary of the 2026 ACC Scientific Statement on gene editing for cardiovascular disease, highlighting indications, recommendations, safety monitoring, ethical issues, and practical steps for integrating these therapies i

Overcoming Barriers to Medical-Legal Partnerships for Veterans Experiencing Intimate Partner Violence: Insights from the VA
Internal MedicineMedical-Legal PartnershipsIntimate Partner Violence

Overcoming Barriers to Medical-Legal Partnerships for Veterans Experiencing Intimate Partner Violence: Insights from the VA

By MedXY|Sep 22, 2026

This qualitative study explores barriers and facilitators to implementing medical-legal partnerships (MLPs) for veterans experiencing intimate partner violence (IPV) within the Veterans Health Administration, highlighting critical organizat

Dapirolizumab Pegol Improves Disease Activity in Systemic Lupus Erythematosus: Evidence from Phase 3 PHOENYCS GO Trial and Prior Studies
Clinical Updatessystemic lupus erythematosusimmunotherapy

Dapirolizumab Pegol Improves Disease Activity in Systemic Lupus Erythematosus: Evidence from Phase 3 PHOENYCS GO Trial and Prior Studies

By MedXY|Sep 22, 2026

Dapirolizumab pegol, a CD40 ligand inhibitor, significantly improves disease activity in moderate-to-severe SLE over 48 weeks when added to standard care, supported by robust phase 3 trial data and pharmacokinetic findings.

Evolving GVHD Prophylaxis in AlloHSCT: Insights from a Large Real-World Spanish Cohort
Hematology-OncologyGVHD prophylaxisAlloHSCT

Evolving GVHD Prophylaxis in AlloHSCT: Insights from a Large Real-World Spanish Cohort

By MedXY|Sep 22, 2026

A large Spanish study reveals the shifting landscape of GVHD prophylaxis in alloHSCT, highlighting widespread post-transplant cyclophosphamide use and its impact on acute and chronic GVHD incidence and survival outcomes.

Unraveling the Risks: T-Cell Lymphoma After CAR T-Cell Therapy—A Rare but Real Concern
Hematology-OncologyCAR T-cell therapyoncoimmunology

Unraveling the Risks: T-Cell Lymphoma After CAR T-Cell Therapy—A Rare but Real Concern

By MedXY|Sep 22, 2026

T-cell lymphomas after CAR T-cell therapy are exceedingly rare but significant. This article reviews incidence, mechanisms, diagnostic challenges, and clinical implications to guide vigilance without overshadowing CAR T-cell therapy’s

Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma
Hematology-Oncologymaintenance therapysurvival outcomes

Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma

By MedXY|Sep 22, 2026

Maintenance therapies—lenalidomide, thalidomide, and bortezomib—significantly improve survival after autologous stem cell transplant for multiple myeloma, regardless of initial response status, based on a large global registry analysis.

Enhancing Bone Marrow Fibrosis Diagnosis: Clinical Evaluation of AI-Driven Continuous Indexing of Fibrosis (CIF)
Hematology-Oncologybone marrow fibrosisAI-assisted diagnostics

Enhancing Bone Marrow Fibrosis Diagnosis: Clinical Evaluation of AI-Driven Continuous Indexing of Fibrosis (CIF)

By MedXY|Sep 22, 2026

This study clinically validates an AI-based quantitative tool, CIF, for bone marrow fibrosis assessment, demonstrating improved reproducibility and accuracy over manual grading without increasing assessment time.

Targeting IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation: A Novel Therapeutic Approach in PTPN11-Mutant Juvenile Myelomonocytic Leukemia
Hematology-Oncologytargeted therapyJuvenile myelomonocytic leukemia

Targeting IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation: A Novel Therapeutic Approach in PTPN11-Mutant Juvenile Myelomonocytic Leukemia

By MedXY|Sep 22, 2026

This study identifies an IL-17A/PTGS2/NLRP3 signaling axis as a key driver of immune suppression and myeloproliferation in PTPN11-mutant JMML, demonstrating that combined inflammasome and PTGS2 inhibition with MEK blockade improves survival

Targeting PKMYT1: A Promising Therapeutic Strategy for High-Risk del(17p) Multiple Myeloma
Hematology-Oncologytargeted therapydel(17p)

Targeting PKMYT1: A Promising Therapeutic Strategy for High-Risk del(17p) Multiple Myeloma

By MedXY|Sep 22, 2026

PKMYT1 inhibition emerges as a selective and effective therapeutic approach against del(17p) high-risk multiple myeloma by inducing lethal DNA damage and mitotic failure.

First-line Ibrutinib Plus Venetoclax in Nonblastoid Mantle Cell Lymphoma: Efficacy and Safety in Older Adults and TP53-Mutant Patients
Hematology-OncologyIbrutinibTP53 突变

First-line Ibrutinib Plus Venetoclax in Nonblastoid Mantle Cell Lymphoma: Efficacy and Safety in Older Adults and TP53-Mutant Patients

By MedXY|Sep 22, 2026

The phase 3 SYMPATICO trial demonstrated that first-line combination therapy with ibrutinib and venetoclax yields high complete response rates and durable remissions in patients ≥65 years or with TP53 mutations suffering from nonblastoid ma

Impact of the 2023 Safety Net Policy on Kidney After Lung Transplantation: Early Changes in Transplant Practices and Outcomes
Nephrologylung transplantationtransplant outcomes

Impact of the 2023 Safety Net Policy on Kidney After Lung Transplantation: Early Changes in Transplant Practices and Outcomes

By MedXY|Sep 22, 2026

Following the 2023 US safety net policy for kidney after lung transplantation, a shift from simultaneous lung-kidney transplants to early kidney transplantation post lung transplant was observed, with improved short-term outcomes and reduce

Dupilumab’s Impact on Mucus Plug Dynamics and Radiodensity in Moderate to Severe Asthma: A CT Imaging Perspective
Allergy & ImmunologydupilumabCT 影像

Dupilumab’s Impact on Mucus Plug Dynamics and Radiodensity in Moderate to Severe Asthma: A CT Imaging Perspective

By MedXY|Sep 22, 2026

Dupilumab treatment in moderate to severe asthma significantly reduces mucus plug burden, resolves existing plugs, limits new plug formation, and decreases plug radiodensity on CT scans, correlating with improved lung function and ventilati

Patient Perceptions of Quality of Shared Decision-Making for Lung Cancer Screening in Telehealth vs In-Person Discussions: A Synthesis of Evidence and Clinical Insights
Clinical UpdatesShared Decision-Makingtelehealth

Patient Perceptions of Quality of Shared Decision-Making for Lung Cancer Screening in Telehealth vs In-Person Discussions: A Synthesis of Evidence and Clinical Insights

By MedXY|Sep 22, 2026

This review synthesizes current evidence comparing patient-perceived quality of shared decision-making (SDM) for lung cancer screening (LCS) delivered via telehealth versus in-person encounters, highlighting comparable outcomes and implicat

Bridging the Gap in Vision Care: Insights from a CFIR-Guided Study on Community-Based Adult Eye Screening in the U.S.
newsKhoa học Triển khaieye health

Bridging the Gap in Vision Care: Insights from a CFIR-Guided Study on Community-Based Adult Eye Screening in the U.S.

By MedXY|Sep 22, 2026

This qualitative study identifies key factors influencing the design, implementation, and sustainability of community-based adult eye screening programs in the U.S., highlighting challenges and opportunities for equitable, scalable vision s

Long-Term Recurrence of Hypertropia After Surgery in Sagging Eye Syndrome: Insights and Implications
newsrecurrencestrabismus surgery

Long-Term Recurrence of Hypertropia After Surgery in Sagging Eye Syndrome: Insights and Implications

By MedXY|Sep 22, 2026

Strabismus surgery effectively corrects hypertropia in sagging eye syndrome (SES), yet about 25% of patients experience delayed recurrent hypertropia over two years, reflecting SES’s progressive nature. Overcorrections are rare and ma

Ultra-Widefield OCT Reveals Distinct Foveal and Optic Nerve Head Topography in Pathologic Myopia with Posterior Staphyloma
newsFoveal TopographyPathologic Myopia

Ultra-Widefield OCT Reveals Distinct Foveal and Optic Nerve Head Topography in Pathologic Myopia with Posterior Staphyloma

By MedXY|Sep 22, 2026

Advanced ultra-widefield OCT mapping elucidates spatial differences in foveal and optic nerve head positioning within posterior staphyloma of pathologic myopia, highlighting distinct remodeling processes and associations with axial length a

Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy: A Clinical Review
Clinical UpdatesPolypoidal Choroidal VasculopathyOCT Biomarkers

Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy: A Clinical Review

By MedXY|Sep 22, 2026

This review synthesizes evidence on PRN aflibercept treatment after complete polypoidal regression in PCV, highlighting recurrence rates, visual outcomes, and potential OCT biomarkers guiding individualized management.

Suzetrigine’s Role in Reducing Opioid Use After Head and Neck Surgery: A Retrospective Cohort Analysis
AnesthesiologySuzetriginePostoperative Pain

Suzetrigine’s Role in Reducing Opioid Use After Head and Neck Surgery: A Retrospective Cohort Analysis

By MedXY|Sep 22, 2026

This study associates adjunctive suzetrigine use with decreased postoperative opioid consumption in patients undergoing head and neck free flap or transoral robotic surgery, without increasing pain scores or adverse events.

Radiofrequency Ablation: A Minimally Invasive Alternative for Thyroid Nodules Post-Lobectomy
Diabetes & Endocrinologyradiofrequency ablationminimally invasive treatment

Radiofrequency Ablation: A Minimally Invasive Alternative for Thyroid Nodules Post-Lobectomy

By MedXY|Sep 22, 2026

Radiofrequency ablation (RFA) provides a safe, effective treatment for thyroid nodules in the remaining lobe after unilateral thyroid lobectomy, offering substantial volume reduction with minimal complications and preserved thyroid function

Prev
7 / 25
1…56789…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles
Family Medicine & Nutrition418 articles